Catalyst Event
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
From Akros SCHK HK-Global High Beta Factor Index (ASHGHBT)
6/4/2026, 12:00:00 AM
Announced an increase in the guarantee limit for subsidiaries by RMB 300 million; operational support is estimated to have a >1% price impact.
Korean Translation
자회사 보증 한도를 3억 위안 증액하여 총 18억 위안으로 상향 조정한다고 발표하였으며, 이는 1% 이상의 주가 영향이 예상되는 결정임.
Related Recent Events
Lumentum Holdings Inc (LITE) · Earnings Release
Lumentum's next earnings release for Q4 2026 is scheduled for August 11, 2026; high importance as a primary volatility driver scheduled.
8/11/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Second Quarter 2026 financial results and conference call are scheduled for 2026-08-06 scheduled.
8/6/2026, 12:00:00 AM
Teradyne Inc (TER) · Earnings Release
High importance is estimated as earnings reports typically drive significant volatility; Q2 2026 earnings release with revenue guidance of $1.15B-$1.25B and non-GAAP EPS of $1.86-$2.15 is scheduled.
8/4/2026, 12:00:00 AM
Monolithic Power Systems Inc (MPWR) · Earnings Release
On 2026-07-30, Q2 2026 earnings release is scheduled and analysts forecast EPS of around $5.85 forecasted. Low importance is estimated as earnings releases typically result in at least a 1% price impact scheduled.
7/30/2026, 12:00:00 AM
Lam Research Corp (LRCX) · Earnings Release
Lam Research is expected to report its Q4 2026 earnings on July 29, 2026. Analysts forecast an EPS of approximately $1.65-$1.68. Market impact is estimated at Medium as earnings reports typically drive significant price volatility, scheduled.
7/29/2026, 12:00:00 AM
Celestica Inc (CLS) · Earnings Release
Celestica is scheduled to release its Q2 2026 financial results on July 27, 2026; market analysis predicts a price impact of over 10% based on historical volatility during earnings, scheduled.
7/27/2026, 12:00:00 AM